TrialDiabetes, obesity & metabolism2022

Combined sodium glucose co-transporter-2 inhibitor and angiotensin-converting enzyme inhibition upregulates the renin-angiotensin system in chronic kidney disease with type 2 diabetes: Results of a randomized, double-blind, placebo-controlled exploratory trial.

Marlies Antlanger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.